These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 23763529)
1. Economic evaluations of point of care testing strategies for active tuberculosis. Zwerling A; Dowdy D Expert Rev Pharmacoecon Outcomes Res; 2013 Jun; 13(3):313-25. PubMed ID: 23763529 [TBL] [Abstract][Full Text] [Related]
2. A modelling framework to support the selection and implementation of new tuberculosis diagnostic tools. Lin HH; Langley I; Mwenda R; Doulla B; Egwaga S; Millington KA; Mann GH; Murray M; Squire SB; Cohen T Int J Tuberc Lung Dis; 2011 Aug; 15(8):996-1004. PubMed ID: 21740663 [TBL] [Abstract][Full Text] [Related]
3. Point-of-care diagnostics for HIV and tuberculosis: landscape, pipeline, and unmet needs. Pai NP; Pai M Discov Med; 2012 Jan; 13(68):35-45. PubMed ID: 22284782 [TBL] [Abstract][Full Text] [Related]
4. Use of Rapid, Point-of-Care Assays by Private Practitioners in Chennai, India: Priorities for Tuberculosis Diagnostic Testing. Bronner Murrison L; Ananthakrishnan R; Sukumar S; Augustine S; Krishnan N; Pai M; Dowdy DW PLoS One; 2016; 11(6):e0155775. PubMed ID: 27304061 [TBL] [Abstract][Full Text] [Related]
5. Public health costs for tuberculosis suspects in Wake County, North Carolina, United States. Park PH; Holland DP; Wade A; Goswami ND; Bissette D; Stout JE Int J Tuberc Lung Dis; 2013 Jun; 17(6):759-63. PubMed ID: 23676158 [TBL] [Abstract][Full Text] [Related]
12. Cost analysis of paediatric tuberculosis treatment in Japan. Rahman M; Takahashi O; Takamatsu I; Sekimoto M; Hira K; Fukui T Int J Tuberc Lung Dis; 2003 Mar; 7(3):254-7. PubMed ID: 12661840 [TBL] [Abstract][Full Text] [Related]
13. Chronic pain: reducing costs through early implementation of adherence testing and recognition of opioid misuse. McCarberg BH Postgrad Med; 2011 Nov; 123(6):132-9. PubMed ID: 22104462 [TBL] [Abstract][Full Text] [Related]
14. TB diagnostic tests: how do we figure out their costs? Sohn H; Minion J; Albert H; Dheda K; Pai M Expert Rev Anti Infect Ther; 2009 Aug; 7(6):723-33. PubMed ID: 19681700 [TBL] [Abstract][Full Text] [Related]
15. Model-based economic evaluations of diagnostic point of care tests were rarely fit for purpose. Breheny K; Sutton AJ; Deeks JJ J Clin Epidemiol; 2019 May; 109():1-11. PubMed ID: 30423377 [TBL] [Abstract][Full Text] [Related]
16. Beyond accuracy: creating a comprehensive evidence base for TB diagnostic tools. Mann G; Squire SB; Bissell K; Eliseev P; Du Toit E; Hesseling A; Nicol M; Detjen A; Kritski A Int J Tuberc Lung Dis; 2010 Dec; 14(12):1518-24. PubMed ID: 21144235 [TBL] [Abstract][Full Text] [Related]
17. Point-of-care diagnosis of tuberculosis: past, present and future. Dheda K; Ruhwald M; Theron G; Peter J; Yam WC Respirology; 2013 Feb; 18(2):217-32. PubMed ID: 23190246 [TBL] [Abstract][Full Text] [Related]
18. Different challenges, different approaches and related expenditures of community-based tuberculosis activities by international non-governmental organizations in Myanmar. Han WW; Saw S; Isaakidis P; Khogali M; Reid A; Hoa N; Zaw KK; Aung ST Infect Dis Poverty; 2017 Mar; 6(1):59. PubMed ID: 28335801 [TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness of novel diagnostic tools for the diagnosis of tuberculosis. Dowdy DW; O'Brien MA; Bishai D Int J Tuberc Lung Dis; 2008 Sep; 12(9):1021-9. PubMed ID: 18713499 [TBL] [Abstract][Full Text] [Related]
20. Tuberculosis diagnostics: test developers' FAQs. Pai M Int J Tuberc Lung Dis; 2013 May; 17(5):570-1. PubMed ID: 23575319 [No Abstract] [Full Text] [Related] [Next] [New Search]